Mortons Neuroma Radiofrequency ablation

Morton’s Neuroma:  Causes, Symptoms, and Treatment with Radiofrequency in Auckland, New Zealand.

​

What is Morton’s Neuroma?
Morton’s Neuroma is a painful condition affecting the ball of the foot, most commonly between the third and fourth toes. It occurs when the tissue surrounding the nerves leading to your toes thickens due to irritation, injury, or pressure, leading to sharp, burning pain, numbness, or discomfort while walking.

​

Radiofrequency Treatment for Morton’s Neuroma
Radiofrequency ablation (RFA) is a minimally invasive procedure used to treat Morton’s Neuroma. This advanced treatment targets the affected nerve using radiofrequency waves, generating heat to disrupt the nerve’s ability to transmit pain signals. 

​

How Does Radiofrequency Treatment Work?
1. Preparation: After identifying the affected nerve, a local anesthetic is applied to numb the area.
2. Insertion: A small needle is inserted near the nerve under ultrasound or X-ray guidance to ensure precision.
3. Radiofrequency Application: Once the needle is properly positioned, radiofrequency waves are delivered, generating heat that desensitizes or destroys the nerve fibers responsible for pain.
4. Completion: The entire procedure takes about 30 minutes, and patients typically experience immediate relief after a short recovery.

​

Efficacy of Radiofrequency Treatment
Radiofrequency ablation offers a high success rate for Morton’s Neuroma, with many patients experiencing long-term relief. Studies show that up to 80-90% of patients report significant pain reduction after the procedure. Additionally, the procedure is safe, minimally invasive, and typically allows patients to return to normal activities within a few days.

For those seeking a non-surgical, effective solution to Morton’s Neuroma, radiofrequency treatment provides a reliable, low-risk option to eliminate pain and improve foot health.

​

The MSK Institute is one of the only places in New Zealand performing this minimally invasive procedure.